seirsplus
covasim
seirsplus | covasim | |
---|---|---|
1 | 2 | |
646 | 242 | |
- | 0.0% | |
0.0 | 8.2 | |
about 1 year ago | 20 days ago | |
Python | Python | |
MIT License | MIT License |
Stars - the number of stars that a project has on GitHub. Growth - month over month growth in stars.
Activity is a relative number indicating how actively a project is being developed. Recent commits have higher weight than older ones.
For example, an activity of 9.0 indicates that a project is amongst the top 10% of the most actively developed projects that we are tracking.
seirsplus
-
SIERS Modeling Primer: Like Pandemic the Game But With More Math
Ryan Mcgee's Python SEIRS Model
covasim
- Daily Coronavirus Megathread - 19 September 2021
-
Agent-based modelling prospects
It's used a lot in epidemiology. Eg: https://github.com/InstituteforDiseaseModeling/covasim
What are some alternatives?
RPICovidScraper - scraper for Rensselaer Polytechnic Institute (RPI)'s Covid Dashboard
coronavirus-dashboard - Dashboard for tracking Coronavirus (COVID-19) across the UK
covid-19-open-data - Datasets of daily time-series data related to COVID-19 for over 20,000 distinct locations around the world.
paperai - 📄 🤖 Semantic search and workflows for medical/scientific papers
epispot - A tool for modeling infectious diseases.
coronavirus-tracker-api - 🦠A simple and fast (< 200ms) API for tracking the global coronavirus (COVID-19, SARS-CoV-2) outbreak. It's written in python using the 🔥 FastAPI framework. Supports multiple sources!
covid-19 - Novel Coronavirus 2019 time series data on cases
covid-vaccine-booking - This tool can be used to automate booking slots on Co-WIN Platform.
COVID19_AgentBasedSimulation - COVID-ABS: An Agent-Based Model of COVID-19 Epidemic to Simulate Health and Economic Effects of Social Distancing Interventions
epysurv - Epidemiological surveillance in Python
covid-19-data - Data on COVID-19 (coronavirus) cases, deaths, hospitalizations, tests • All countries • Updated daily by Our World in Data
corona - Reverse engineering SARS-CoV-2